A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

See what infectious disease doctors have to say as government officials appear poised to scale back COVID vaccines and the FDA approved the Novavax vaccine with new limitations.

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not needed to conduct additional tests on each year’s updated vaccine. It's similar to the way the annual flu shot is updated to target the newest influenza strains,

The new, narrower FDA approval will likely reduce both access to COVID-19 vaccines for the general ... long they will stay authorized and how the change will affect childhood vaccination overall.